A new model of renal microvascular endothelial injury

Kidney International

Volumn 52, Issue 1, 1997, Pages 182-194

  Nangaku, Masaomi ^a   Alpers, Charles E ^b   Pippin, Jeffrey ^b   Shankland, Stuart J ^b   Adler, Stephen ^b   Kurokawa, Kiyoshi ^b   Couser, William G ^b   Johnson, Richard J ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b NONE

Author keywords

Endothelium; Hemolytic uremic syndrome; Platelet; Thrombotic microangiopathy; Tubulointerstitial disease

Indexed keywords

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; GOAT; HISTOPATHOLOGY; KIDNEY BLOOD VESSEL; KIDNEY INJURY; KIDNEY TUBULE NECROSIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR ENDOTHELIUM;

EID: 0030862795     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.318     Document Type: Article

References (85)

1. GERRITSEN ME, BLOOR CM: Endothelial cell gene expression in response to injury. FASEB J 7:523-532, 1993
2. COTRAN RS, POBER JS: Effects of cytokines on vascular endothelium: Their role in vascular and immune injury. Kidney Int 35:969-975, 1989
3. PALL AA, SAVAGE COS: Mechanisms of endothelial cell injury in vasculitis. Springer Semin Immunopathol 16:23-37, 1994
4. RUGGENENTI P, REMUZZI G: Malignant vascular disease of the kidney: Nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomy. Am J Kidney Dis 27:459-475, 1996
5. NORIS M, REMUZZI G: New insights into circulating cell-endothelium interactions and their significance for glomerular pathophysiology. Am J Kidney Dis 26:541-548, 1995
6. STEWART RJ, MARSDEN PA: Vascular endothelial cell activation in models of vascular and glomerular injury. Kidney Int 45(Suppl 45): S37-S44, 1994
7. SAVAGE COS: The biology of glomerulus: Endothelial cells. Kidney Int 45:314-319, 1994
8. TAKANO T, BRADY HR: The endothelium in glomerular inflammation. Curr Opin Nephrol Hypertens 4:277-286, 1995
9. ALPERS CE, HUDKINS KL, PRITZL P, JOHNSON RJ: Mechanisms of clearance of immune complexes from peritubular capillaries in the rat. Am J Pathol 139:855-867, 1991
10. ADLER S, ENG B: Integrin receptors and function on cultured glomerular endothelial cells. Kidney Int 44:278-284, 1993
11. Russo C, CALLEGARO L, LANZA E, FERRONE S: Purification of IgG monoclonal antibody by caprylic acid precipitation. J Immunol Meth 65:269-271, 1983
12. NANGAKU M, PIPPIN J, RICHARDSON CA, SCHULZE M, YOUNG BA, ALPERS CE, GORDON KL, JOHNSON RJ, COUSER WG: Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy. Kidney Int 50:2054-2062, 1996
13. DUIJVESTIJN AM, VAN GOOR H, KLATTER F, MAJOOR GD, VAN BUSSEL E, VAN BREDA VRIESMAN PJC: Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody. Lab Invest 66:459-466, 1992
14. BAGCHUS WM, JEUNINK MF, ROZING J, ELEMA JD: A monoclonal antibody against rat platelets. I. Tissue distribution in vitro and in vivo. Clin Exp Immunol 75:317-323, 1989
15. SKALLI O, ROPRAZ P, TRZECIAK A, BENZONANA G, GILLESSEN D, GABBIANI G: A monoclonal antibody against. J Cell Biol 103:2787-2796, 1986
16. PLATE KH, BREIER G, WEICH HA, RISAU W: Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359:845-848, 1992
17. MCKEE M, SCAVONE C, NATHANSON JA: Nitrix oxide, cGMP, and hormone regulation of active sodium transport. Proc Natl Acad Sci USA 91:12056-12060, 1994
18. IRUELA-ARISPE L, GORDON K, HUGO C, DUIJVESTIJN AM, CLAFFEY KP, REILLY M, COUSER WG, ALPERS CE, JOHNSON RJ: Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis, Am J Pathol 147:1715-1727, 1995
19. BRADLEY GM, BENSON ES: Examination of the urine, in Clinical Diagnosis by Laboratory Methods (Todd-Stanford, 15th ed), edited by DAVIDSON I, HENRY JB, Philadelphia, WB Saunders, 1974
20. REMUZZI G, RUGGENENTI P: The hemolytic uremic syndrome. Kidney Int 47:2-19, 1995
21. SIEGLER RL: Hemolytic uremic syndrome in children. Curr Opin Pediatr 7:159-163, 1995
22. GRIMM PC, OGBORN MR: Hemolytic uremic syndrome: The most common cause of acute renal failure in childhood. Pediatr Ann 23:505-511, 1994
23. SIEGLER RL: The hemolytic uremic syndrome. Pediatr Clin N Am 42:1505-1529, 1995
24. BOYCE TG, SWERDLOW DL, GRIFFIN PM: Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 333:364-368, 1995
25. RONDEAU E, PERALDI M-N: Escherichia coli and the hemolyticuremic syndrome. N Engl J Med 335:660-662, 1996
26. ZOJA C, CORNA D, FARINA C, SACCHI G, LINGWOOD C, DOYLE MP, PADHYE VV, ABBATE M, REMUZZI G: Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. J Lab Clin Med 120:229-238, 1992
27. MATSUO S, FUKATSU A, TAUB ML, CALDWELL PRB, BRENTJENS JR, ANDRES G: Glomerulonephritis induced in the rabbit by antiendothelial antibodies. J Clin Invest 79:1798-1811, 1987
28. MATSUDA M: Experimental glomerular tissue injury induced by immunization with cultured endothelial cell plasma membrane. Acta Pathol Jpn 38:823-839, 1988
29. GOLBUS SM, WILSON CB: Experimental glomerulonephritis induced by in situ formation of immune complexes in glomerular capillary wall. Kidney Int 16:148-157, 1979
30. BRETTON R, BARIETY J: Ultrastructural localization of concanavalin A in normal rat kidney - glomeruli and arterioles. J Ultrastruct Res 48:396-403, 1974
31. 2-halide system in immune complex nephritis. Kidney Int 32:342-349, 1987
32. JOHNSON RJ, ALPERS CE, PRITZL P, SCULZE M, BAKER P, PRUCHNO C, COUSER WG: Platelets mediate neutrophil-dependent immune complex nephritis in the rat. J Clin Invest 82:1225-1235, 1988
33. JOHNSON RJ, ALPERS CE, PRUCHNO C, SCHULZE M, BAKER PJ, PRITZL P, COUSER WG: Mechanisms and kinetics for platelet and neutrophil localization in immune complex nephritis. Kidney Int 36:780-789, 1989
34. FRIES JW, MENDRICK DL, RENNKE HG: Determinants of immune complex-mediated glomerulonephritis. Kidney Int 34:333-345, 1988
35. SEKIYAMA S, YOSHIDA F, YUZAWA Y, FUKATSU A, SUZUKI N, SAKAMOTO N, MATSUO S: Mesangial proliferate glomerulonephritis induced in rats by a lentil lectin and its antibodies. J Lab Clin Med 121:71-82, 1993
36. KINCAID-SMITH P, FAIRLEY KF, KLOSS M: Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Q J Med 69:795-815, 1988
37. AMIGO M-C, GARCTA-TORRES R, ROBLES M, BOCHICCHIO T, REYES PA: Renal involvement in primary antiphospholipid syndrome. J Rheumatol 19:1181-1185, 1992
38. HUGHSON MD, NADASDY T, MCCARTY GA, SHOLER C, MIN K-W, SILVA F: Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kid Dis 20:150-158, 1992
39. D'AGATI V, KUNIS C, WILLIAMS G, APPEL GB: Anti-cardiolipin antibody and renal disease: A report of three cases. J Am Soc Nephrol 1:777-784, 1990
40. BANFI G, BERTANI T, BOERI V, FARAGGIANA T, MAZZUCCO G, MONGA G, SACCHI G, GISNE L: Renal vascular lesions as a marker of poor diagnosis in patients with lupus nephritis. Am J Kid Dis 18:240-248, 1991
41. HEPTINSTALL RH: Hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, and systemic sclerosis (systemic scleroderma), in Pathology of the Kidney (4th ed, vol II), edited by HEPTINSTALL RH, Boston, Little, Brown, and Company, 1992
42. FARRUGIA E, TORRES VE, GASTINEAU D, MICHET CJ, HOLLEY KE: Lupus anticoagulant in systemic lupus erythematosus: A clinical and renal pathological study. Am J Kid Dis 5:463-471, 1992
43. BECQUEMONT L, THERVET E, RONDEAU E, LACAVE R, MOUGENOT B, SRAER J-D: Systemic and renal fibrinolytic activity in a patient with anticardiolipin syndrome and renal thrombotic microangiopathy. Am J Nephrol 10:254-258, 1990
44. PIETTE J-C, CACOUB P, WECHSLER B: Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 23:357-366, 1994
45. MAGIL AB, MCFADDEN D, RAE A: Lupus glomerulonephritis with thrombotic microangiopathy. Hum Pathol 17:192-194, 1986
46. STRIKER LJ, OLSON JL, STRIKER GE: The Renal Biopsy (2nd ed. vol 8), Major Problems in Pathology, edited by BENNINGTON JL, Philadelphia, W.B. Saunders Company; 1990
47. GAGNADOUS MF, HABIB R, GUBLER MC, BACRI JL, BROYER M: Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome. Clin Nephrol 46:39-41, 1996
48. KILGORE KS, FLORY CM, MILLER BF, EVANS VM, WARREN JS: The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am J Pathol 149:953-961, 1996
49. KAKIZAKI Y, WAGA S, SUGIMOTO K, TANAKA H, NUKII K, TAKEYA M, YOSHIMURA T, YOKOYAMA M: Production of monocyte chemoattractant protein-1 by bovine glomerular endothelial cells. Kidney Int 48:1866-1874, 1995
50. COUSER WG, JOHNSON RJ, YOUNG BA, YEH CG, TOTH CA, RUDOLPH AR: The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis. J Am Soc Nephrol 5:1888-1894, 1995
51. MATSUO S, YOSHIDA F, YUZAWA Y, HARA S, FUKATSU A, WATANABE Y, SAKAMOTO N: Experimental glomerulonephritis induced in rats by a lectin and its antibodies. Kidney Int 36:1011-1021, 1989
52. UCHIDA K, UCHIDA S, NITTA K, YUMURA W, MARUMO F, NIHEI H: Glomerular endothelial cells in culture express and secrete vascular endothelial cell growth factor. Am J Physiol 266:F81-F88, 1994
53. BALLERMANN BJ: Regulation of bovine glomerular endothelial cell growth in vitro. Am J Physiol 256:C182-C189, 1989
54. SENGER DR, GALLI SJ, DVORAK AM, PERRUZZI CA, HARVEY VS, DVORAK HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985, 1983
55. CONNOLLY DT, HEUVELMAN DM, NELSON R, OLANDER JV, EPPLEY BL, DELFINO JJ, SIEGEL NR, LEIMGRUBER RM, FEDER J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478, 1989
56. SENGER DR, CONNOLLY DT, LIVINGSTON VDW, FEDER J, DVORAK HF: Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 50:1774-1778, 1990
57. JAKEMAN LB, WINER J, BENNETT GL, ALTAR CA, FERRARA N: Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89:244-253, 1992
58. SIMON M, GRONE H-J, JOHREN O, KULLMER J, PLATE KH, RISAU W, FUCHS E: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268:F240-F250, 1995
59. BERSE B, BROWN LF, VAN DE: WATER HF, DVORAK HF, SENGER DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3:211-220, 1992
60. BROWN LF, BERSE B, TOGNAZZI K, MANSEAU EJ, VAN DE WATER L, SENGER DR, DVORAK HF, ROSEN S: Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 42:1457-1461, 1992
61. GRONE H-J, SIMON M, GRONE EF: Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol 177:259-267, 1995
62. BREIER G, ALBRECHT U, STERRER S, RISAU W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114:521-532, 1992
63. JOHNSON RJ, FLOEGE J, YOSHIMURA A, IIDA H, COUSER WG, ALPERS CE: The activated mesangial cell: a glomerular "myofibroblast"? J Am Soc Nephrol 2:S190-S197, 1992
64. DEL CASTILLO D, RAIJ L: Pathophysiology of the interaction between mesangium and endothelium. Contrib Nephrol 111:29-37, 1995
65. BENZAQUEN LR, NICHOLSON-WELLER A, HALPERIN JA: Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J Exp Med 179:985-992, 1994
66. UCHIDA K, BALLERMANN BJ: Sustained activation of PGE2 synthesis in mesangial cells cocultured with glomerular endothelial cells. Am J Physiol 263:C200-C209, 1992
67. NAGLE RB, KNEISER MR, BULGER RE, BENDITT EP: Induction of smooth muscle characteristics in renal interstitial fibroblasts during obstructive nephropathy. Lab Invest 29:422-427, 1973
68. DIAMOND JR, VAN GOOR H, DING G, ENGELMYER E: Myofibroblasts in experimental hydronephrosis. Am J Pathol 146:121-129, 1995
69. PEARSON JD: Vessel wall interactions regulating thrombosis. Br Med Bull 50:776-788, 1994
70. MARCUS AJ, SAFIER LB, BROEKMAN MJ, ISLAM N, FLIESSBACH JH, HAJJAR KA, KAMINSKI WE, JENDRASCHAK E, SILVERSTEIN RL, VON SCHACKY C: Thrombosis and inflammation as multicellular processes: Significance of cell-cell interactions. Thromb Haemos 74:213-217, 1995
71. STAMLER J, MENDELSOHN ME, AMARANTE P, SMICK D, ANDON N, DAVIES PF, COOKE JP, LOSCALZO J: N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 65:789-795, 1989
72. BROEKMAN MJ, EIROA AM, MARCUS AJ: Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension. Blockade of aggregation and secretion by an aspirin-insensitive mechanism. Blood 78:1033-1040, 1991
73. RADOMSKI MW, PALMER RMJ, MONCADA S: The anti-aggregatory properties of vascular endothelium: interactions between prostacyciln and nitric oxide. Br J Pharmacol 92:639-646, 1987
74. RADOMSKI MW, PALMER RMJ, MONCADA S: Comparative pharmacology of endothelium-dependent relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 92:181-187, 1987
75. DE GRAAF JC, BANGA JD, MONCADA S, PALMER RMJ, DE GROOT PG, SIXMA JJ: Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 85:2284-2290, 1992
76. RADOMSKI MW, PALMER MJ, MONCADA S: The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 148:1482-1489, 1987
77. RAIJ L, COFFEE K, GUERRA J, HOLMES D: Glomerular thrombosis in pregnancy: Role of the L-arginine-nitric oxide pathway. Kidney Int 45:775-781, 1994
78. SHULTZ PJ, RAIJ L: Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 90:1718-1725, 1992
79. WESTBERG G, SHULTZ PJ, RAIJ L: Exogenous nitric oxide prevents endotoxin-induced glomerular thrombosis in rats. Kidney Int 46:711-716, 1994
80. DE BELDER A, LEES C, MARTIN J, MONCADA S, CAMPBELL S: Treatment of HELLP syndrome with nitric oxide donor. Lancet 345:124-125, 1995
81. BACHMANN S, BOSSE HM, MUNDEL P: Topography of nitric oxide synthesis by localizing constitutive NO synthase in mammalian kidney. Am J Physiol 268:F885-F898, 1995
82. UJIIL: K, YUEN J, HOGARTH L, DANZIGER R, STAR RA: Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. Am J Physiol 267:F296-F302, 1994
83. GOTO S, YAMAMOTO T, FENG L, YAOITA E, HIROSE S, FUJINAKA H, KAWASAKI K, HATTORI R, YUI Y, WILSON CB, ARAKAWA M, KIHARA I: Expression and localization of inducible nitric oxide synthase in anti-Thy-1 glomerulonephritis. Am J Pathol 147:1133-1141, 1995
84. CONGER J, ROBINETTE J, VILLAR A, RAIJ L, SHULTZ P: Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats. J Clin Invest 96:631-638, 1995
85. NORIS M, RUGGENENTI P, TODESCHINI M, FIGLIUZZI M, MACCONI D, ZOJA C, PARIS S, GASPARI F, REMUZZI G: Increased nitric oxide formation in recurrent thrombotic microangiopathies: A possible mediator of microvascular injury. Am J Kid Dis 27:790-796, 1996